C
Carolina Rivas
Researcher at University of Miami
Publications - 3
Citations - 817
Carolina Rivas is an academic researcher from University of Miami. The author has contributed to research in topics: Vaccination & Medicine. The author has an hindex of 3, co-authored 3 publications receiving 78 citations.
Papers
More filters
Journal ArticleDOI
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
Mark W Tenforde,Wesley H. Self,Katherine Adams,Manjusha Gaglani,Adit A. Ginde,Tresa McNeal,Shekhar Ghamande,David J. Douin,H. Keipp Talbot,Jonathan D Casey,Nicholas M. Mohr,Anne Zepeski,Nathan I. Shapiro,Kevin W Gibbs,D. Clark Files,David N. Hager,Arber Shehu,Matthew E. Prekker,Heidi L Erickson,Matthew C. Exline,Michelle N. Gong,Amira Mohamed,Daniel J. Henning,Jay S. Steingrub,Ithan D. Peltan,Samuel M. Brown,Emily T. Martin,Arnold S. Monto,Akram Khan,Catherine L. Hough,Laurence W. Busse,Caitlin C Ten Lohuis,Abhijit Duggal,Jennifer G. Wilson,Alexandra June Gordon,Nida Qadir,Steven Y. Chang,Christopher Mallow,Carolina Rivas,Hilary M. Babcock,Jennie H. Kwon,Natasha B. Halasa,James D. Chappell,Adam S. Lauring,Carlos G. Grijalva,Todd W. Rice,Ian Jones,William B Stubblefield,Adrienne Baughman,Kelsey N Womack,Jillian P. Rhoads,Christopher J. Lindsell,Kimberly W. Hart,Yuwei Zhu,Samantha M. Olson,Miwako Kobayashi,Jennifer R. Verani,Manish M. Patel,Influenza +58 more
TL;DR: In this article, the authors evaluated the association between vaccination with mRNA COVID-19 vaccines and hospitalization, and the association with progression to critical disease, using multivariable logistic regression.
Journal ArticleDOI
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
Wesley H. Self,Mark W Tenforde,Jillian P. Rhoads,Manjusha Gaglani,Manjusha Gaglani,Adit A. Ginde,David J. Douin,Samantha M. Olson,H. Keipp Talbot,Jonathan D Casey,Nicholas M. Mohr,Anne Zepeski,Tresa McNeal,Tresa McNeal,Shekhar Ghamande,Shekhar Ghamande,Kevin W Gibbs,D. Clark Files,David N. Hager,Arber Shehu,Matthew E. Prekker,Heidi L Erickson,Michelle N. Gong,Amira Mohamed,Daniel J. Henning,Jay S. Steingrub,Ithan D. Peltan,Samuel M. Brown,Emily T. Martin,Arnold S. Monto,Akram Khan,Catherine L. Hough,Laurence W. Busse,Caitlin C Ten Lohuis,Abhijit Duggal,Jennifer G. Wilson,Alexandra June Gordon,Nida Qadir,Steven Y. Chang,Christopher Mallow,Carolina Rivas,Hilary M. Babcock,Jennie H. Kwon,Matthew C. Exline,Natasha B. Halasa,James D. Chappell,Adam S. Lauring,Carlos G. Grijalva,Todd W. Rice,Ian Jones,William B. Stubblefield,Adrienne Baughman,Kelsey N Womack,Christopher J. Lindsell,Kimberly W. Hart,Yuwei Zhu,Lisa Mills,Sandra N. Lester,Megan M. Stump,Eric A. Naioti,Miwako Kobayashi,Jennifer R. Verani,Natalie J. Thornburg,Manish M. Patel +63 more
TL;DR: In this paper, a case-control analysis was conducted among 3,689 adults aged ≥18 years who were hospitalized at 21 U.S. hospitals across 18 states during March 11-August 15, 2021.
Journal ArticleDOI
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
Mark W Tenforde,Wesley H. Self,Eric A. Naioti,Adit A. Ginde,David J. Douin,Samantha M. Olson,H. Keipp Talbot,Jonathan D Casey,Nicholas M. Mohr,Anne Zepeski,Manjusha Gaglani,Manjusha Gaglani,Tresa McNeal,Shekhar Ghamande,Nathan I. Shapiro,Kevin W Gibbs,D. Clark Files,David N. Hager,Arber Shehu,Matthew E. Prekker,Heidi L Erickson,Michelle N. Gong,Amira Mohamed,Daniel J. Henning,Jay S. Steingrub,Ithan D. Peltan,Samuel M. Brown,Emily T. Martin,Arnold S. Monto,Akram Khan,Catherine L. Hough,Laurence W. Busse,Caitlin C Ten Lohuis,Abhijit Duggal,Jennifer G. Wilson,Alexandra June Gordon,Nida Qadir,Steven Y. Chang,Christopher Mallow,Carolina Rivas,Hilary M. Babcock,Jennie H. Kwon,Matthew C. Exline,Natasha B. Halasa,James D. Chappell,Adam S. Lauring,Carlos G. Grijalva,Todd W. Rice,Ian Jones,William B. Stubblefield,Adrienne Baughman,Kelsey N Womack,Christopher J. Lindsell,Kimberly W. Hart,Yuwei Zhu,Meagan Stephenson,Stephanie J. Schrag,Miwako Kobayashi,Jennifer R. Verani,Manish M. Patel +59 more
TL;DR: In this article, Pfizer-BioNTech or Moderna mRNA COVID-19 vaccines were evaluated in 21 hospitals in 18 states and the duration of mRNA vaccine effectiveness against COVID19-associated hospitalizations was assessed among adults aged ≥18 years.